<HashMap><database>biostudies-literature</database><scores/><additional><submitter>McKenzie C</submitter><funding>NIA NIH HHS</funding><funding>U.S. Department of Defense</funding><funding>National Institutes of Health</funding><funding>CIHR</funding><pagination>119-127</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC12903205</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>88</volume><pubmed_abstract>Cognitive reserve has been described as offering protection against Alzheimer's disease (AD) and other neurodegenerative conditions, but also against age-associated brain changes. Using data from the Alzheimer's Disease Neuroimaging Initiative, we defined cognitive reserve using the residual reserve index: episodic memory performance residualized for 3T MRI-derived brain volumes and demographics. We examined whether cognitive reserve predicted executive function (EF) decline equally across 2 groups of older adults-AD biomarker-positive (n = 468) and -negative (n = 402)-defined by the tau-to-amyloid ratio in cerebrospinal fluid. A significant interaction between the residual reserve index and biomarker group revealed that the effect of cognitive reserve on EF decline was dependent on pathol</pubmed_abstract><journal>Neurobiology of aging</journal><pubmed_title>Cognitive reserve predicts future executive function decline in older adults with Alzheimer's disease pathology but not age-associated pathology.</pubmed_title><pmcid>PMC12903205</pmcid><funding_grant_id>U01 AG024904</funding_grant_id><pubmed_authors>Bourgeat P</pubmed_authors><pubmed_authors>Alzheimer's Disease Neuroimaging Initiative</pubmed_authors><pubmed_authors>McKenzie C</pubmed_authors><pubmed_authors>Weinborn M</pubmed_authors><pubmed_authors>Bucks RS</pubmed_authors><pubmed_authors>Salvado O</pubmed_authors><pubmed_authors>Gavett BE</pubmed_authors></additional><is_claimable>false</is_claimable><name>Cognitive reserve predicts future executive function decline in older adults with Alzheimer's disease pathology but not age-associated pathology.</name><description>Cognitive reserve has been described as offering protection against Alzheimer's disease (AD) and other neurodegenerative conditions, but also against age-associated brain changes. Using data from the Alzheimer's Disease Neuroimaging Initiative, we defined cognitive reserve using the residual reserve index: episodic memory performance residualized for 3T MRI-derived brain volumes and demographics. We examined whether cognitive reserve predicted executive function (EF) decline equally across 2 groups of older adults-AD biomarker-positive (n = 468) and -negative (n = 402)-defined by the tau-to-amyloid ratio in cerebrospinal fluid. A significant interaction between the residual reserve index and biomarker group revealed that the effect of cognitive reserve on EF decline was dependent on pathol</description><dates><release>2020-01-01T00:00:00Z</release><publication>2020 Apr</publication><modification>2026-07-15T15:34:33.8Z</modification><creation>2026-07-06T03:11:23.116Z</creation></dates><accession>S-EPMC12903205</accession><cross_references><pubmed>31980279</pubmed><doi>10.1016/j.neurobiolaging.2019.12.022</doi></cross_references></HashMap>